84% ORR (32 of 38 patients) and 71% CR (27 of 38 patients) documented after 2 million cells/kg dose anbal-cel treatment to patients in relapsed/refractory large B-cell lymphoma Durable complete response was measured-68% at 1 month, 61% at 3 months, and 60% at 6 months respectively….
Month: June 2023
DUBLIN, June 19, 2023 /PRNewswire/ — The “Barcode Label Printer Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the barcode label…
NEW YORK, June 19, 2023 /PRNewswire/ — Levi & Korsinsky notifies investors that it has commenced an investigation of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN) concerning possible violations of federal securities laws. On or around April 22, 2021, Rain conducted its…
— FDA has provided clearance to the company to continue dosing patients who have already undergone lymphodepletion — REDWOOD CITY, Calif., June 19, 2023 /PRNewswire/ — Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative…
NEW YORK, June 19, 2023 /PRNewswire/ — The athletic footwear market size in US is forecast to increase by USD 3,231.02 million from 2022 to 2027, at a CAGR of 3.28%, according to the recent market study by Technavio. The growth of the market will be driven by the popularity of sports and…
DUBLIN, June 19, 2023 /PRNewswire/ — The “Generic Central Nervous System Drugs Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the…